Rare Disease

Pioneering Rare Disease Research

Rare disease trials necessitate a partner that can think quickly and provide innovative solutions that advance your promising therapies for the patients that need them most. Rare and orphan diseases often place tremendous burden on patients and their loved ones, and each patient and data point is critical in developing therapies for these unmet medical needs. Rare diseases can impact one or many systems within the body, complicating clinical trial monitoring. Additionally, patient recruitment presents a serious obstacle to achieving enrollment goals. Conventional approaches that work for large clinical studies may not work in the realm of rare and orphan diseases. It is critical to partner with a CRO experienced in rare disease research, capable of developing a strong study design and creative, patient-centric recruitment plans. Linical delivers innovative strategies, fresh perspective, and attention-to-detail, because we realize even the smallest of trials can have a huge impact on the wellbeing of patients.

Leading CRO for Rare Disease Clinical Trials

Linical has a passion for rare disease clinical research, and our project teams are invested in your project’s success from planning to study close out. We partner with clients to understand your trial’s unique needs, adding value no matter how complex the indication. We have a proven track record of success in managing rare and orphan disease studies across many indications and phases. Linical leverages medical experts, key opinion leaders (KOLs), specialized sites, patient registries and support groups, and natural history studies to achieve successful outcomes. From small trials to larger scale, global projects, Linical is your trusted CRO for orphan and rare disease research.